Sex based pharmacological treatment in patients with metabolic syndrome: Findings from the Isfahan healthy heart program

Mojgan Gharipour¹*, Roya Kelishadi², Nafiseh Toghianifar², Mahsa Mackie³, Mehrdad Yazdani², Fatemeh Noori⁴ and Nizal Sarrafzadegan²

¹Department of Biochemistry, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

²Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

³Centre for Neuroscience, University of Alberta, Canada.

⁴Statistical sciences, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Received: 2017-01-18Accepted: 2025-03-18Published: 2017-01-18

Int. J. Pharm. & Pharmacol. 2015, 6(1), 1-6

Disclaimer: The statements, opinions and data contained in this journal are solely those of the individual authors and contributors and not of Macao Scientific Publishers and/or the editors. Macao Scientific Publishers and/or the editors disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content.